{"id":45124,"date":"2022-06-15T18:01:24","date_gmt":"2022-06-15T16:01:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/"},"modified":"2022-06-15T18:01:24","modified_gmt":"2022-06-15T16:01:24","slug":"eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/","title":{"rendered":"EU Regulatory Report 2022: The Kanavape Ruling’s Impact on EU Harmonization of CBD – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: The Kanavape Ruling’s Impact On EU Harmonization Of CBD”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nSince the publishing of the Kanavape decision in November 2020, some EU member states are still non-compliant with it, and a number of member states still view as illegal CBD-containing vape products, hemp flowers, and extraction from flowers.\n<\/p>\n

\nThis report aims to analyze the developments of the European CBD regulatory landscape almost one and a half years after the crucial ruling of the Kanavape case.\n<\/p>\n

\nSpecifically, the analysis focuses on the compliance by EU member states with the decision of the Court of Justice of the European Union (CJEU) in different policy areas and the direct impact on European Commission (EC) policy decisions.\n<\/p>\n

\nKey Topics Covered:<\/strong>\n<\/p>\n

\n1 Executive Summary\n<\/p>\n

\n2 Introduction\n<\/p>\n

\n3 Kanavape Case\n<\/p>\n

\n4 Developments Toward Harmonization\n<\/p>\n

\n5 The Future Of Kanavape and EU Harmonization On CBD\n<\/p>\n

\n6 Member States’ Compliance With The Kanavape Ruling\n<\/p>\n

\nFor more information about this report visit https:\/\/www.researchandmarkets.com\/r\/fbqtqr<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nResearchAndMarkets.com
\n
Laura Wood, Senior Press Manager
\n
press@researchandmarkets.com<\/a>
For E.S.T Office Hours Call 1-917-300-0470
\n
For U.S.\/CAN Toll Free Call 1-800-526-8630
\n
For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: The Kanavape Ruling’s Impact On EU Harmonization Of CBD” report has been added to ResearchAndMarkets.com’s offering. Since the publishing of the Kanavape decision in November 2020, some EU member states are still non-compliant with it, and a number of member states still view as illegal CBD-containing vape products, hemp flowers, and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45124","6":"format-standard","7":"category-industry"},"yoast_head":"\nEU Regulatory Report 2022: The Kanavape Ruling's Impact on EU Harmonization of CBD - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU Regulatory Report 2022: The Kanavape Ruling's Impact on EU Harmonization of CBD - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: The Kanavape Ruling’s Impact On EU Harmonization Of CBD” report has been added to ResearchAndMarkets.com’s offering. Since the publishing of the Kanavape decision in November 2020, some EU member states are still non-compliant with it, and a number of member states still view as illegal CBD-containing vape products, hemp flowers, and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-15T16:01:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220615005878\/en\/1487877\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"EU Regulatory Report 2022: The Kanavape Ruling’s Impact on EU Harmonization of CBD – ResearchAndMarkets.com\",\"datePublished\":\"2022-06-15T16:01:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\\\/\"},\"wordCount\":222,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220615005878\\\/en\\\/1487877\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\\\/\",\"name\":\"EU Regulatory Report 2022: The Kanavape Ruling's Impact on EU Harmonization of CBD - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220615005878\\\/en\\\/1487877\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-15T16:01:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220615005878\\\/en\\\/1487877\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220615005878\\\/en\\\/1487877\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU Regulatory Report 2022: The Kanavape Ruling’s Impact on EU Harmonization of CBD – ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EU Regulatory Report 2022: The Kanavape Ruling's Impact on EU Harmonization of CBD - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"EU Regulatory Report 2022: The Kanavape Ruling's Impact on EU Harmonization of CBD - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: The Kanavape Ruling’s Impact On EU Harmonization Of CBD” report has been added to ResearchAndMarkets.com’s offering. Since the publishing of the Kanavape decision in November 2020, some EU member states are still non-compliant with it, and a number of member states still view as illegal CBD-containing vape products, hemp flowers, and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-15T16:01:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220615005878\/en\/1487877\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"EU Regulatory Report 2022: The Kanavape Ruling’s Impact on EU Harmonization of CBD – ResearchAndMarkets.com","datePublished":"2022-06-15T16:01:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/"},"wordCount":222,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220615005878\/en\/1487877\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/","name":"EU Regulatory Report 2022: The Kanavape Ruling's Impact on EU Harmonization of CBD - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220615005878\/en\/1487877\/21\/logo.jpg","datePublished":"2022-06-15T16:01:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220615005878\/en\/1487877\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220615005878\/en\/1487877\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/eu-regulatory-report-2022-the-kanavape-rulings-impact-on-eu-harmonization-of-cbd-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"EU Regulatory Report 2022: The Kanavape Ruling’s Impact on EU Harmonization of CBD – ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45124"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45124\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}